According to a newly published market research report by 24LifeSciences, global Bruton's Tyrosine Kinase (BTK) inhibitors market was valued at USD 6,941 million in 2024 and is projected to reach USD 9,622 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period. BTK inhibitors are small molecule therapeutics that selectively inhibit the Bruton's...

According to a newly published market research report by 24LifeSciences, global Bruton's Tyrosine Kinase (BTK) inhibitors market was valued at USD 6,941 million in 2024 and is projected to reach USD 9,622 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period. BTK inhibitors are small molecule therapeutics that selectively inhibit the Bruton's...

According to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...

The global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...

According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...

According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...

According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...